Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by Gemcitabine in an androgen-reduced environment

We examined the efficacy of combination treatments utilizing cytotoxic drugs plus inhibitors to members of the ErbB - ERK signal pathway in human prostate cancer (PCa) LNCaP C-81 cells. Under an androgen-reduced condition, 50 nM gemcitabine caused about 40% growth suppression on C-81 cells. Simultan...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhang, Li, Davis, Jeffrey S., Zelivianski, Stanislav, Lin, Fen-Fen, Schutte, Rachel, Davis, Thomas L., Hauke, Ralph, Batra, Surinder K., Lin, Ming-Fong
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2780578/
https://ncbi.nlm.nih.gov/pubmed/19467571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2009.04.041
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars